<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39365759</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>In vitro 5-LOX inhibitory and antioxidant potential of isoxazole derivatives.</ArticleTitle><Pagination><StartPage>e0297398</StartPage><MedlinePgn>e0297398</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0297398</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0297398</ELocationID><Abstract><AbstractText>5-Lipoxygenase (5-LOX) is a key enzyme involved in the biosynthesis of pro-inflammatory leukotrienes, leading to asthma. Developing potent 5-LOX inhibitors are highly attractive. In this research the previously synthesized isoxazole derivatives has been investigated against 5-LOX inhibitory and antioxidant in vitro assay. The compound 3 caused concentration dependent inhibition of 5-LOX with overall IC50 value of 8.47 μM. The investigated compounds C5 also exhibited good 5-LOX inhibitory effect. The IC50 demonstrated for C5 was 10.48. Among the 10 synthesized compounds, the potential 5-LOX inhibitory effect was reported for C6. The most potent compound which showed excellent free radical scavenging effect was C3 having IC50 value of 10.96 μM. The next most potent antioxidant activity was reported for C5 which non-significantly showed free radical scavenging effect. The IC50 value observed for C5 was 13.12 μM. Compound C6 also showed potent dose dependent antioxidant effect with IC50 value of 18.87 μM having percent inhibition of 91.63±0.55, 88.45±0.49, 83.53±0.45, 78.42±0.66 and 73.72±0.64 at concentration 1000-62.5 μg/mL respectively. Among the tested compounds, C6 was found most potent which showed significant 5-LOX percent inhibition assay and also reported the minimum IC50 value comparable to the reference drug. The in vitro 5-LOX enzymes inhibition assays of C5 and C3 also showed excellent percent inhibition and good potency next to C6. We concluded that amongst the investigated designed molecules the C3 was found best potent and showed significant dose dependent antioxidant activity against DPPH screening. The IC50 value reported for C3 was found good as compared to standard drug. Moreover, C5 and C6 also showed excellent free radical scavenging effect against DPPH assay. Computational methods have also been employed to explore the probable interaction model of inhibitors and enzyme active sites, and also to correlate the results of in silico and in vitro studies.</AbstractText><CopyrightInformation>Copyright: © 2024 Alam et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alam</LastName><ForeName>Waqas</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Haroon</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1736-4404</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jan</LastName><ForeName>Muhammad Saeed</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0003-2411-6510</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, Bacha Khan University, KP, Charsadda, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W Darwish</LastName><ForeName>Hany</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daglia</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, University of Napoli Federico II, Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>A Elhenawy</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Chemistry Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016859">Lipoxygenase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.11.34</RegistryNumber><NameOfSubstance UI="D001094">Arachidonate 5-Lipoxygenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007555">Isoxazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016166">Free Radical Scavengers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010851">Picrates</NameOfSubstance></Chemical><Chemical><RegistryNumber>DFD3H4VGDH</RegistryNumber><NameOfSubstance UI="C004931">1,1-diphenyl-2-picrylhydrazyl</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001713">Biphenyl Compounds</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016859" MajorTopicYN="Y">Lipoxygenase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="Y">Antioxidants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001094" MajorTopicYN="Y">Arachidonate 5-Lipoxygenase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007555" MajorTopicYN="Y">Isoxazoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016166" MajorTopicYN="N">Free Radical Scavengers</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010851" MajorTopicYN="N">Picrates</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001713" MajorTopicYN="N">Biphenyl Compounds</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>I have read the journal’s policy, and the authors of this manuscript have the following competing interests: Institution.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>19</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>18</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>13</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39365759</ArticleId><ArticleId IdType="pmc">PMC11452043</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0297398</ArticleId><ArticleId IdType="pii">PONE-D-24-00443</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kretzer C, Jordan PM, Meyer KP, Hoff D, Werner M, et al.. (2022) Natural chalcones elicit formation of specialized pro-resolving mediators and related 15-lipoxygenase products in human macrophages. Biochemical pharmacology 195: 114825. doi: 10.1016/j.bcp.2021.114825</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2021.114825</ArticleId><ArticleId IdType="pubmed">34762841</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam VC. Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections; 2013. Elsevier. pp. 240–248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3885417</ArticleId><ArticleId IdType="pubmed">24084369</ArticleId></ArticleIdList></Reference><Reference><Citation>Variya BC, Bakrania AK, Patel SS (2016) Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms. Pharmacological research 111: 180–200. doi: 10.1016/j.phrs.2016.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2016.06.013</ArticleId><ArticleId IdType="pubmed">27320046</ArticleId></ArticleIdList></Reference><Reference><Citation>Biringer RG (2020) The enzymology of human eicosanoid pathways: The lipoxygenase branches. Molecular Biology Reports 47: 7189–7207. doi: 10.1007/s11033-020-05698-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05698-8</ArticleId><ArticleId IdType="pubmed">32748021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenis JM, Gillman JD, Lee JD, Shannon JG, Bilyeu KD (2010) Soybean seed lipoxygenase genes: molecular characterization and development of molecular marker assays. Theoretical and Applied Genetics 120: 1139–1149. doi: 10.1007/s00122-009-1241-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00122-009-1241-9</ArticleId><ArticleId IdType="pubmed">20058147</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaschler MM, Stockwell BR (2017) Lipid peroxidation in cell death. Biochemical and biophysical research communications 482: 419–425. doi: 10.1016/j.bbrc.2016.10.086</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.10.086</ArticleId><ArticleId IdType="pmc">PMC5319403</ArticleId><ArticleId IdType="pubmed">28212725</ArticleId></ArticleIdList></Reference><Reference><Citation>Abibindhu S, Nair S, Kannan C (2022) SYNTHESIS AND ANTI-INFLAMMATORY, ANTIOXIDANT STUDIES OF NOVEL CHALCONES-BASED ISOXAZOLE DERIVATIVES. Rasayan Journal of Chemistry 15.</Citation></Reference><Reference><Citation>Sadiq A, Mahnashi MH, Alyami BA, Alqahtani YS, Alqarni AO, et al.. (2021) Tailoring the substitution pattern of Pyrrolidine-2, 5-dione for discovery of new structural template for dual COX/LOX inhibition. Bioorganic chemistry 112: 104969. doi: 10.1016/j.bioorg.2021.104969</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioorg.2021.104969</ArticleId><ArticleId IdType="pubmed">34023639</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshehri OM, Shabnam M, Asiri SA, Mahnashi MH, Sadiq A, et al.. (2024) Isolation, invitro, invivo anti-inflammatory, analgesic and antioxidant potential of Habenaria plantegania Lindl. Inflammopharmacology: 1–17. doi: 10.1007/s10787-023-01425-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01425-4</ArticleId><ArticleId IdType="pubmed">38334860</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthuraman S, Sinha S, Vasavi C, Waidha KM, Basu B, et al.. (2019) Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies. Bioorganic &amp; Medicinal Chemistry 27: 604–619. doi: 10.1016/j.bmc.2018.12.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2018.12.043</ArticleId><ArticleId IdType="pubmed">30638966</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann B, Steinhilber D (2013) 5-Lipoxygenase inhibitors: a review of recent patents (2010–2012). Expert opinion on therapeutic patents 23: 895–909. doi: 10.1517/13543776.2013.791678</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543776.2013.791678</ArticleId><ArticleId IdType="pubmed">23600432</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Sravanthi T, Yuvaraj S, Manju S, Doble M (2016) 2-Amino-4-aryl thiazole: a promising scaffold identified as a potent 5-LOX inhibitor. RSC advances 6: 19271–19279.</Citation></Reference><Reference><Citation>Tomy MJ, Sharanya CS, Dileep KV, Prasanth S, Sabu A, et al.. (2015) Derivatives form better lipoxygenase inhibitors than piperine: in vitro and in silico study. Chemical Biology &amp; Drug Design 85: 715–721. doi: 10.1111/cbdd.12455</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cbdd.12455</ArticleId><ArticleId IdType="pubmed">25327968</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Mo J, Lin H-z, Chen Y, Sun H-p (2018) The recent progress of isoxazole in medicinal chemistry. Bioorganic &amp; Medicinal Chemistry 26: 3065–3075. doi: 10.1016/j.bmc.2018.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2018.05.013</ArticleId><ArticleId IdType="pubmed">29853341</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell B (1996) Antioxidants in human health and disease. Annual review of nutrition 16: 33–50. doi: 10.1146/annurev.nu.16.070196.000341</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.nu.16.070196.000341</ArticleId><ArticleId IdType="pubmed">8839918</ArticleId></ArticleIdList></Reference><Reference><Citation>Grune T, Shringarpure R, Sitte N, Davies K (2001) Age-related changes in protein oxidation and proteolysis in mammalian cells. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 56: B459–B467. doi: 10.1093/gerona/56.11.b459</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/56.11.b459</ArticleId><ArticleId IdType="pubmed">11682566</ArticleId></ArticleIdList></Reference><Reference><Citation>Noguchi N, Niki E (2000) Phenolic antioxidants:: A rationale for design and evaluation of novel antioxidant drug for atherosclerosis. Free radical biology and medicine 28: 1538–1546. doi: 10.1016/s0891-5849(00)00256-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0891-5849(00)00256-2</ArticleId><ArticleId IdType="pubmed">10927179</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Z, Moore J, Yu L (2006) High-throughput relative DPPH radical scavenging capacity assay. Journal of agricultural and food chemistry 54: 7429–7436. doi: 10.1021/jf0611668</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf0611668</ArticleId><ArticleId IdType="pubmed">17002404</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaik A, Bhandare RR, Palleapati K, Nissankararao S, Kancharlapalli V, et al.. (2020) Antimicrobial, antioxidant, and anticancer activities of some novel isoxazole ring containing chalcone and dihydropyrazole derivatives. Molecules 25: 1047. doi: 10.3390/molecules25051047</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25051047</ArticleId><ArticleId IdType="pmc">PMC7179112</ArticleId><ArticleId IdType="pubmed">32110945</ArticleId></ArticleIdList></Reference><Reference><Citation>Palleapati K, Kancharlapalli VR, Shaik AB (2019) Synthesis, characterization and antitubercular evaluation of some new isoxazole appended 1-carboxamido-4, 5-dihydro-1H-pyrazoles. J Res Pharm 23: 156–163.</Citation></Reference><Reference><Citation>Bhatia R, Vyas A, El-Bahy SM, Hessien MM, Mersal GA, et al.. (2022) Rationale Design, Synthesis, Pharmacological and In-silico Investigation of Indole-Functionalized Isoxazoles as Anti-inflammatory Agents. ChemistrySelect 7: e202200800.</Citation></Reference><Reference><Citation>Alam W, Khan H, Jan MS, Rashid U, Abusharha A, et al.. (2023) Synthesis, in-vitro inhibition of cyclooxygenases and in silico studies of new isoxazole derivatives. Frontiers in Chemistry 11. doi: 10.3389/fchem.2023.1222047</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2023.1222047</ArticleId><ArticleId IdType="pmc">PMC10511884</ArticleId><ArticleId IdType="pubmed">37744065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisastra R, Kok PA, Eleftheriadis N, Baumgartner MP, Camacho CJ, et al.. (2013) Discovery of a novel activator of 5-lipoxygenase from an anacardic acid derived compound collection. Bioorganic &amp; medicinal chemistry 21: 7763–7778. doi: 10.1016/j.bmc.2013.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4017091</ArticleId><ArticleId IdType="pubmed">24231650</ArticleId></ArticleIdList></Reference><Reference><Citation>Braca A, Tommasi ND, Bari LD, Pizza C, M P, et al.. (2001) Antioxidant principles from Bauhinia terapotensis. Journal of Natural Products 64: 892–895.</Citation><ArticleIdList><ArticleId IdType="pubmed">11473417</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy EJ, Metcalfe CL, Basran J, Moody PC, Raven EL (2008) Engineering the substrate specificity and reactivity of a heme protein: creation of an ascorbate binding site in cytochrome c peroxidase. Biochemistry 47: 13933–13941. doi: 10.1021/bi801480r</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi801480r</ArticleId><ArticleId IdType="pubmed">19061385</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert NC, Rui Z, Neau DB, Waight MT, Bartlett SG, et al.. (2012) Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at Serine-663. The FASEB Journal 26: 3222. doi: 10.1096/fj.12-205286</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.12-205286</ArticleId><ArticleId IdType="pmc">PMC3405276</ArticleId><ArticleId IdType="pubmed">22516296</ArticleId></ArticleIdList></Reference><Reference><Citation>Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, et al.. (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of medicinal chemistry 47: 1739–1749. doi: 10.1021/jm0306430</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm0306430</ArticleId><ArticleId IdType="pubmed">15027865</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava P, Vyas VK, Variya B, Patel P, Qureshi G, et al.. (2016) Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives. Bioorganic Chemistry 67: 130–138. doi: 10.1016/j.bioorg.2016.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioorg.2016.06.004</ArticleId><ArticleId IdType="pubmed">27376460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur G, Silakari O (2017) Multiple target-centric strategy to tame inflammation. Future Medicinal Chemistry 9: 1361–1376. doi: 10.4155/fmc-2017-0050</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc-2017-0050</ArticleId><ArticleId IdType="pubmed">28771028</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HT, Vu T-Y, Chandi V, Polimati H, Tatipamula VB (2020) Dual COX and 5-LOX inhibition by clerodane diterpenes from seeds of Polyalthia longifolia (Sonn.) Thwaites. Scientific Reports 10: 15965. doi: 10.1038/s41598-020-72840-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72840-8</ArticleId><ArticleId IdType="pmc">PMC7524750</ArticleId><ArticleId IdType="pubmed">32994508</ArticleId></ArticleIdList></Reference><Reference><Citation>Koukoulitsa C, Hadjipavlou–Litina D, Geromichalos GD, Skaltsa H (2007) Inhibitory effect on soybean lipoxygenase and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum. Journal of Enzyme Inhibition and Medicinal Chemistry 22: 99–104. doi: 10.1080/14756360600991017</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756360600991017</ArticleId><ArticleId IdType="pubmed">17373554</ArticleId></ArticleIdList></Reference><Reference><Citation>Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier J-P (2003) Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Annals of the Rheumatic Diseases 62: 501–509. doi: 10.1136/ard.62.6.501</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.62.6.501</ArticleId><ArticleId IdType="pmc">PMC1754580</ArticleId><ArticleId IdType="pubmed">12759283</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakesh KS, Jagadish S, Balaji KS, Zameer F, Swaroop TR, et al.. (2016) 3, 5-Disubstituted isoxazole derivatives: Potential inhibitors of inflammation and cancer. Inflammation 39: 269–280. doi: 10.1007/s10753-015-0247-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-015-0247-5</ArticleId><ArticleId IdType="pubmed">26363638</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain Y, Khan H, Alam W, Ali Z, Ibrar M (2022) Curcumin targeting oxidative mediators for therapeutic effects in diabetes and its related complications. PHYTONutrients: 17–35.</Citation></Reference><Reference><Citation>Yatoo GN, Banday JA (2023) Synthesis, antioxidant, antiproliferative activity, molecular docking and DFT studies of novel isoxazole derivatives of diosgenin, a steroidal sapogenin from Dioscorea deltoidea. Fitoterapia 170: 105621. doi: 10.1016/j.fitote.2023.105621</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fitote.2023.105621</ArticleId><ArticleId IdType="pubmed">37524127</ArticleId></ArticleIdList></Reference><Reference><Citation>Banoglu E, Çelikoğlu E, Völker S, Olgaç A, Gerstmeier J, et al.. (2016) 4, 5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP). European Journal of Medicinal Chemistry 113: 1–10. doi: 10.1016/j.ejmech.2016.02.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2016.02.027</ArticleId><ArticleId IdType="pubmed">26922224</ArticleId></ArticleIdList></Reference><Reference><Citation>Mphahlele MJ, Nkoana JK, Gildenhuys S, Elhenawy AA (2024) Structure and biological property studies of the fluorinated sulfonic esters derived from 2-hydroxy-4-(hydroxy/methoxy) acetophenone as inhibitors of biochemical targets linked to type 2 diabetes mellitus. Journal of Fluorine Chemistry 273: 110233.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>